ARID3A Activators encompass a spectrum of compounds that indirectly augment the functional activity of ARID3A through a variety of cellular mechanisms. Forskolin, by increasing intracellular cAMP, indirectly enhances ARID3A's transcriptional regulation by activating protein kinase A (PKA), which can phosphorylate substrates that cooperate with ARID3A in gene regulation. Similarly, Epigallocatechin gallate, through kinase inhibition, may reduce competition from phosphorylating enzymes, allowing ARID3A to more effectively bind DNA and modulate gene expression. Phorbol 12-myristate 13-acetate (PMA), as a PKC activator, along with PI3K inhibitors like LY294002, and mTOR inhibitor Rapamycin, all contribute to ARID3A's activation by modulating transcription factors and proteins that interact with or regulate ARID3A's activity, leading to enhanced gene transcription.
The action of ARID3A is further influenced by compounds that modulate chromatin structure and DNA accessibility. Trichostatin A, as a histone deacetylase inhibitor, promotes a transcriptionally active chromatin environment, potentially enhancing ARID3A's access to DNA and its transcriptional activity. 5-Azacytidine, by inhibiting DNA methylation, could also facilitate ARID3A's interaction with DNA. Moreover, signaling pathway modulators such as SB203580 and U0126, which inhibit p38 MAPK and MEK1/2, respectively, may shift the equilibrium of cellular signaling to favor ARID3A's activation by altering the activities of transcription factors that work alongside ARID3A. Additionally, Thapsigargin and Resveratrol orchestrate the activation of ARID3A through the modulation of intracellular calcium levels and activation of sirtuins, respectively, each pathway converging to enhance the transcriptional regulation prowess of ARID3A.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn can activate PKA. PKA phosphorylation can alter various transcription factors and proteins, potentially increasing ARID3A's DNA-binding activity and enhancing its role in transcriptional regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that promotes acetylation of histones, leading to a more open chromatin structure and potentially enhancing ARID3A's access to its DNA-binding sites, thereby increasing its transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that reduces DNA methylation, which may facilitate ARID3A binding to previously methylated DNA regions, enhancing its regulatory effects on gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences gene expression by activating retinoic acid receptors, which can interact with ARID3A on certain gene promoters, enhancing ARID3A's role in gene regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, a kinase inhibitor, may reduce competition for ARID3A transcription factor binding sites on DNA by inhibiting other kinases that phosphorylate competing factors, thus enhancing ARID3A's activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate transcription factors and proteins that interact with ARID3A, potentially enhancing its transcriptional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, which can alter the activity of transcription factors that regulate ARID3A function, leading to an enhanced ARID3A activity in gene regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter signaling pathways, potentially affecting transcription factors that regulate ARID3A activity, indirectly enhancing ARID3A's role in gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can lead to changes in protein synthesis and transcription factor activity. This may enhance ARID3A-mediated transcription by altering the expression of genes that interact with ARID3A. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins, which can deacetylate proteins and influence transcription factor activity. This might enhance ARID3A's transcriptional regulation by modifying the interaction between ARID3A and other transcriptional regulators. | ||||||